Nearly a year ago, I reviewed Zoetis (NYSE: ZTS ) and stated that the company was a “Buy.” My reasoning was that the company remained a leader in a niche industry and has continued to grow revenue despite someAnalyst’s Disclosure:I/we have a beneficial long position in the shares of ZTS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relatio ...